Filament Health to Webcast Live at VirtualInvestorConferences.com April 28th

VANCOUVER, British Columbia, April 25, 2022 -- Filament Health , a clinical-stage natural psychedelic drug development company, today announced that Benjamin Lightburn, CEO and Co-Founder,... | April 25, 2022

Related Keywords

United States ,United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Tim Regan ,Adam Holdsworth ,Benjamin Lightburn ,Johnm Viglotti ,Corporate Services ,Instagram ,Linkedin ,Psyence Group ,Twitter ,Drug Administration ,Journey Centers ,Filament Health ,Trademark Office ,Strategic Communications ,Division Of Psychiatry ,Globenewswire Inc ,United States Patent ,United States Food ,Cybin Therapeutics ,Virtual Investor Conferences ,Investor Conferences ,Virtual Investor ,Filament Health Corp Stock Exchange ,News ,Information ,Press Release ,Pril ,022 ,Filament ,Health ,Natural ,Sychedelic ,Drug ,Development ,Oday ,Benjamin ,Ceo ,Nd Flhlf Ca31685w1068 ,